Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 5/20 | 0.38 |
| ▸ | RAB9A | P51151 | 5/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | CCNC | P24863 | 1/20 | 0.38 |
| ▸ | CDK8 | P49336 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13242139 | 0.76 | KAT2B (0.40) | PKMNPC1RAB9ACCNCCDK8 | |
| SCHEMBL1742856 | 0.75 | MAPT (0.39) | NPC1RAB9ACCNCCDK8SMN1; SMN2 | |
| SCHEMBL1742858 | 0.75 | MAPT (0.39) | NPC1RAB9ACCNCCDK8SMN1; SMN2 | |
| SCHEMBL2552457 | 0.74 | ALDH1A1 (0.50) | RAB9ASMN1; SMN2MAPTHTTLMNA | |
| SCHEMBL8782043 | 0.73 | PKM (0.45) | PKMGPR84NPC1RAB9ACCNC | |
| SCHEMBL4001406 | 0.73 | KAT2B (0.38) | PKMNPC1RAB9ACCNCCDK8 | |
| SCHEMBL2572082 | 0.72 | HTT (0.50) | PKMSMN1; SMN2MAPTHTTL3MBTL1 | |
| SCHEMBL7500922 | 0.72 | ALDH1A1 (0.57) | GPR84PDE4BNPC1RAB9ATAAR1 | |
| SCHEMBL7034304 | 0.71 | PTGER4 (0.43) | PKMCCNCCDK8SMN1; SMN2MAPT | |
| SCHEMBL8606335 | 0.70 | PKM (0.37) | PKMNPC1RAB9ATAAR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6392049-B1 | NITRATION USING NITRIC ACID | AVENTIS PHARMACEUTICALS INC. | 2002-05-21 | — | — | US | disclosed |
| US-6307054-B1 | HEATING A 5-CARBOXY-2,4-DIHYROXYPYRIDINE AND PHOSPHORIC ACID WHERE THE RATIO OF PHOSPHORIC ACID TO WATER IS NOT LESS THAN ABOUT 27 TO 1 WEIGHT %. | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1006115-A2 | Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-06-07 | — | — | EP | disclosed |
| EP-0909270-A1 | PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-04-21 | — | — | EP | disclosed |
| EP-0909270-A4 | — | — | 1999-04-21 | — | — | EP | disclosed |
| EP-0758897-A4 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE POULENC RORER PHARMA (US) | 1997-11-19 | — | — | EP | disclosed |
| US-5652366-A | ADENOSINE AGONISTS; HYPOTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTILIPOLYTIC AGENTS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-29 | — | — | US | disclosed |
| WO-1997024327-A1 | PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| EP-0758897-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1997-02-26 | — | — | EP | disclosed |
| US-5561134-A | ADENOSINE DERIVATIVES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-10-01 | — | — | US | disclosed |
| WO-1995028160-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1995-10-26 | — | — | WO | disclosed |
| US-5364862-A | Adenosine derivatives | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-11-15 | — | — | US | disclosed |
| EP-0550631-A4 | COMPOUNDS HAVING ANTIHYPERTENSIVE AND ANTI-ISCHEMIC PROPERTIES | RHONE POULENC RORER INT (US) | 1994-08-10 | — | — | EP | disclosed |
| EP-0550631-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE AND ANTI-ISCHEMIC PROPERTIES. | RHONE POULENC RORER INT (US) | 1993-07-14 | — | — | EP | disclosed |
| WO-1992005177-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE AND ANTI-ISCHEMIC PROPERTIES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-04-02 | — | — | WO | disclosed |